Aug 15, 2019 08:30AM
Aug 15, 2019 08:30AM
Apr 18, 2019 01:00AM
Apr 11, 2019 12:01PM
Apr 11, 2019 12:00PM
Apr 9, 2019 12:29PM
Mar 7, 2019 02:55PM Clementia Pharmaceuticals Inc. Obtains Interim Order for Proposed Transaction With Ipsen S.A. and Enters Into Support and Voting Agreements With Two Additional Significant Shareholders
Mar 7, 2019 01:00PM
Feb 26, 2019 06:30AM
Feb 26, 2019 06:30AM
Feb 25, 2019 09:25AM
Feb 25, 2019 06:11AM
Feb 25, 2019 01:00AM
Feb 11, 2019 06:32AM Clementia (CMTA) Granted Rare Pediatric Disease Designation by FDA for Palovarotene for FOP
Feb 11, 2019 06:30AM
Feb 11, 2019 06:30AM
Nov 30, 2018 09:00AM
Nov 30, 2018 09:00AM
Nov 21, 2018 06:30AM
Nov 21, 2018 06:30AM
Nov 7, 2018 06:30AM Clementia Reports Third Quarter 2018 Operating Results and Pipeline Updates
Nov 7, 2018 06:30AM
Oct 30, 2018 05:52AM
Oct 29, 2018 09:21PM
Oct 29, 2018 09:21PM
Oct 29, 2018 04:29PM
Oct 29, 2018 04:01PM
Oct 29, 2018 04:01PM Clementia Announces Proposed Public Offering of Common Shares
Oct 24, 2018 09:31AM
Oct 23, 2018 05:55PM
Oct 23, 2018 04:01PM
Oct 23, 2018 04:01PM
Oct 23, 2018 04:01PM
Sep 26, 2018 08:32AM
Sep 26, 2018 08:30AM Clementia Announces Updated Phase 2 Part B Data on Palovarotene for FOP
Sep 26, 2018 08:30AM
Aug 16, 2018 06:31AM
Aug 16, 2018 06:30AM
Aug 16, 2018 06:30AM
May 23, 2018 06:33AM
May 23, 2018 06:30AM
May 23, 2018 06:30AM Clementia Reports Positive Phase 2 Part B Data Showing Treatment with Palovarotene Significantly Reduces New Bone Growth in Patients with FOP
Apr 20, 2018 06:39AM
Apr 20, 2018 06:30AM
Apr 20, 2018 06:30AM
Dec 12, 2017 06:35AM
Dec 12, 2017 06:30AM
Dec 12, 2017 06:30AM
Nov 13, 2017 08:00AM Clementia Reports Third Quarter 2017 Financial Results and Business Highlights
Aug 31, 2017 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All